FSE$FMS
Fresenius Medical Care AG & Co. KGAA · Q2 2026 earnings
Q2 2026 earnings · · Investor relations
Briefing
Fresenius Medical Care reported Q2 2026 revenue of EUR 4.861 billion with operating income rising 10% to EUR 466 million.
Fresenius Medical Care AG & Co. KGaA delivered another quarter of highly profitable growth in Q2 2026, with organic revenue growth of 5% and operating income excluding special items up 23% at constant currency to EUR 569 million, expanding margins to 11.7%. The company advanced its FME Reignite strategy through clinic optimizations, new machine rollouts, and share buybacks while reaffirming its full-year 2026 outlook.
- Group revenue EUR 4,861 million, +1% yoy (+4% cc, +5% organic)
- Operating income EUR 466 million (+10% yoy), excl. special items EUR 569 million (+20% yoy, +23% cc)
- Net income EUR 218 million (-3% yoy), basic EPS EUR 0.81 (+6% yoy); excl. special items EPS EUR 1.13 (+24% yoy)
- Reaffirmed FY 2026 outlook; net leverage ratio stable at 2.6x
Headline financials
Revenue & EPS history
Fresenius Medical Care · Revenue · Quarterly
€5.6B
Revenue by segment
Fresenius Medical Care · €5.39B total across 3 segments · Q2 2026
- Care Delivery€3.48B—64.6%
- Care Enablement€1.37B—25.5%
- Value-Based Care€536M—10.0%
Forward guidance
Reaffirms FY 2026 outlook following solid Q2 performance in line with planned phasing.
Tailwinds
- Organic revenue growth across segments
- Margin expansion and cost savings from FME25+ program
- Progress on 5008X CAREsystem rollout and share buybacks
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
+0.1%
Avg return
Earnings day
-1.3%
Avg return
5 days after
+0.2%
Avg return
30 days after
16%
11 / 67 earnings
Positive
+23.1%
Q1 2011
Best reaction
-8.9%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q4 2026 | -6.7% | -1.3% | +55.7% | |
| Q4 2024 | +0.0% | +3.9% | +5.3% | |
| Q2 2024 | +0.0% | -6.4% | -4.9% | |
| Q4 2023 | +6.7% | -8.2% | -9.7% | |
| Q3 2023 | +0.0% | +2.0% | +24.6% | |
| Q2 2023 | +0.0% | +0.2% | -7.9% | |
| Q1 2023 | -0.5% | +1.3% | +0.2% | |
| Q4 2022 | +6.9% | +0.0% | +1.6% | |
| Q3 2022 | +0.0% | +7.9% | +11.3% | |
| Q2 2022 | +0.0% | -18.6% | -24.4% | |
| Q1 2022 | -8.9% | -4.7% | -9.3% | |
| Q4 2021 | +0.0% | -2.1% | -2.5% | |
| Q3 2021 | -4.6% | +4.3% | -10.8% | |
| Q2 2021 | +0.0% | -3.2% | -5.7% | |
| Q1 2021 | +0.0% | -1.0% | +3.6% | |
| Q4 2020 | +0.0% | -3.1% | +3.5% | |
| Q3 2020 | +0.0% | -2.5% | +6.5% | |
| Q2 2020 | +0.0% | -4.9% | -9.2% | |
| Q1 2020 | +0.0% | +2.9% | +13.6% | |
| Q4 2019 | +3.1% | -4.2% | -28.6% | |
| Q3 2019 | +3.3% | +10.5% | +10.8% | |
| Q2 2019 | -8.8% | -10.1% | -11.5% | |
| Q1 2019 | +6.7% | -1.8% | -12.6% | |
| Q4 2018 | +0.0% | +3.8% | +0.5% | |
| Q3 2018 | -1.9% | -2.8% | +4.0% | |
| Q2 2018 | +0.0% | +0.9% | +8.3% | |
| Q1 2018 | +0.0% | -2.5% | -3.6% | |
| Q4 2017 | -2.5% | -5.8% | -6.7% | |
| Q3 2017 | -0.5% | +0.2% | +2.6% | |
| Q2 2017 | +0.0% | -1.3% | -0.1% | |
| Q1 2017 | +0.0% | +1.5% | +6.7% | |
| Q4 2016 | +0.0% | +0.8% | +1.8% | |
| Q3 2016 | +0.0% | +0.5% | -2.5% | |
| Q2 2016 | +2.6% | +1.0% | -4.5% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | +1.1% | — | — | |
| Q3 2015 | +5.4% | — | — | |
| Q2 2015 | -4.7% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +7.0% | — | — | |
| Q3 2014 | +0.0% | — | — | |
| Q2 2014 | -4.5% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2012 | -6.4% | — | — | |
| Q4 2013 | -6.4% | — | — | |
| Q3 2013 | +0.0% | — | — | |
| Q2 2013 | -3.7% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q3 2012 | +0.0% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | -0.6% | — | — | |
| Q4 2011 | +1.4% | — | — | |
| Q3 2011 | +0.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q1 2011 | +23.1% | — | — | |
| Q4 2010 | +0.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q1 2010 | +0.0% | — | — | |
| Q1 2009 | +0.0% | — | — | |
| Q4 2009 | +0.0% | — | — | |
| Q4 2007 | +0.0% | — | — | |
| Q3 2008 | +0.0% | — | — | |
| Q3 2009 | +0.0% | — | — | |
| Q2 2008 | +0.0% | — | — | |
| Q4 2008 | +0.0% | — | — | |
| Q2 2009 | +0.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro